The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.20
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.30 (25.00%)
Open: 1.35
High: 1.35
Low: 1.35
Prev. Close: 1.35
IGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

18 May 2011 07:00

RNS Number : 7862G
Image Scan Holdings PLC
18 May 2011
 



18 May 2011

 

IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

(AIM: IGE)

 

INTERIM RESULTS

FOR THE SIX MONTHS ENDED 31 MARCH 2011

 

Image Scan, the AIM-listed specialist supplier of real-time 3D and 2D x-ray screening systems to the homeland security and industrial inspection markets, today announces its interim results for the six months ended 31 March 2011.

 

 

Financial Highlights:

·; Revenue decreased by 16% to £772,000 (2010: £922,000)

·; Gross profit margin at 41% (2010: 54%)

·; Overheads down to £582,000 (2010: £604,000)

·; Loss on ordinary activities after taxation of £266,000 (2010: loss £108,000)

·; Period-end cash of £197,000 (2010: £643,000)

 

Operational Highlights:

·; Current year order intake of £1.8m

·; Orders received from across a range of security, industrial and nuclear sectors

·; First sales of the new compact portable FlatScan-15 x-ray screening system following launch in 2011

 

Corporate Highlight:

·; Announcement of placing of 15m new ordinary shares at 2p each to a strategic investor

 

 

 

Brian Emslie, Chairman of Image Scan, commented: "Whilst the interim results are disappointing, the Board feels encouraged by the visibility on current orders and the expected sales for the current year. Order intake, now standing at £1.8m for the year to date, has resulted from demand for the expanded security product range primarily from new markets in Asia and the Middle East, combined with significant industrial orders in segments where the Company can add value and has a proven track record. The proceeds of the proposed placing as announced today are necessary to provide the Company with additional working capital to fulfil its order book and move towards achieving its key short term goal of breakeven. "

 

 

 

Enquiries:

 

Image Scan Holdings plc Tel: +44 (0) 1509 503 400

Brian Emslie, Chairman

Louise George, CEO

ir@ish.co.uk

 

Seymour Pierce Tel: +44 (0) 207 107 8000

Sarah Jacobs / John Cowie

 

 

 

CHAIRMAN'S STATEMENT

Introduction

In recent months there have been signs that the strategy adopted by the Company in the last two years of building a sales team focused on selling standard x-ray security inspection systems whilst pursuing high value industrial opportunities is beginning to come to fruition. Therefore, it is with some regret that in reporting on the Company's interim results for the six months ended 31 March 2011, the impact of the increased order intake during the period is not reflected in these first half results.

 

Financial results

Revenue for the six months was down 16% to £772,000 (2010: £922,000) and reflected a sales mix of security, industrial and nuclear contracts, reversing the recent trend of sales being predominantly from the security sector. This change of mix is reflected in the gross margin moving from 54% to 41% in the period.

 

Overheads were reduced further to £582,000 (2010: £604,000) with an increase in headcount being countered by the one-off costs of moving offices and establishing a new website incurred in 2010. The resultant net loss was £266,000 (2010: loss £108,000) and the loss per share was 0.43p (2010: 0.19p).

 

Delivery of standard systems from stock has required the Company to increase its stock levels to meet customer delivery expectations. This level of stock requirement has inevitably placed pressure on the working capital position, and this will increasingly be the case as the product range is extended further. Coupled with the loss for the period, the cash balance has fallen by £151,000 since the year end to £197,000. The Company has an agreed £100,000 overdraft facility with the Royal Bank of Scotland.

 

Overview

Security revenue arose predominately from the FlatScan system and reflected the efforts of the sales team to build up sales channels into new territories offering standard security products to a wider range of potential end users. Meanwhile the security market in Europe has been weakened through the reduction in public spending, such that sales into this territory have receded. In March 2011 the Company launched its new smaller panel version of the FlatScan system, FlatScan-15, for which orders have already been secured.

 

The Company has continued to offer tailored solutions within the industrial and nuclear sectors to meet strategic high value opportunities. This approach has resulted in industrial revenue of £535,000 during the period which included the extension to the new MDXi software platform, a small nuclear contract, and work in progress on the build of two industrial MDXi-NT systems and a major nuclear contract.

 

Outlook

The Company's current year order intake stands at £1.8m. This represents £1,160,000 of industrial orders including two nuclear contracts totaling £830,000 and two further orders totaling £330,000 from another key industrial customer which is very encouraging given the lack of activity in the industrial market in the previous two years. The remainder represents orders of standard security products comprising numerous smaller orders mainly from developing markets in the Middle East and Asia.

 

Despite a disappointing first half, the Board is encouraged by the visibility on current orders and expected sales for the current year. With the brought forward order book of £90,000 and the expectation of £400,000 being delivered in the financial year ended September 2012, known contracted sales deliverable in the current financial year stand at £1.5m, and which already exceeds the total sales achieved for the year ended 30 September 2010.

 

Continued focus on cost management and careful management of assets and cash flows have enabled the Company to achieve its change in strategy. However, with the cash balance standing at £114,000 on 16 May 2011, the Directors believe that the proceeds of the proposed placing announced today will provide the necessary additional working capital to allow the Company more flexibility in fulfilling its order book and moving towards achieving its key short term goal of breakeven. The placing is for the issue of 15,000,000 new ordinary shares at 2p to a strategic investor based in Hong Kong. The Board understands that the investor believes there are opportunities for the Company's products in Asia and wishes to invest in the Company to provide the focus for both reducing the cost of key components through overseas sourcing and for opening up routes to market in the region.

 

Brian Emslie

Chairman

17 May 2011

 

CONSOLIDATED INCOME STATEMENT

for the six months ended 31 March 2011

Six months to

Six months to

Year to

31 March 2011

31 March 2010

30 September 2010

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Revenue

772

922

1,472

Cost of sales

(456)

(427)

(666)

Gross profit

316

495

806

Administrative expenses

(582)

(604)

(1,218)

Operating loss

(266)

(109)

(412)

Finance revenue

-

1

2

Loss before taxation

(266)

(108)

(410)

Taxation

-

-

28

Loss for the period

(266)

(108)

(382)

Pence

Pence

Pence

Earnings per share

Basic and diluted loss per share

0.43

0.19

0.65

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

for the six months ended 31 March 2011

Six months to

Six months to

Year to

31 March 2011

31 March 2010

30 September 2010

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Opening equity shareholders' funds

814

1,079

1,079

Issue of shares - at par

-

56

56

Issue of shares - share premium

-

56

56

Share-based payments

2

2

5

Loss attributable to equity shareholders

(266)

(108)

(382)

550

1,085

814

 

 

CONSOLIDATED BALANCE SHEET

as at 31 March 2011

As at

As at

As at

31 March 2011

 31 March 2010

 30 September 2010

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Non-current assets

Plant and equipment

43

96

49

Intangible assets

-

-

-

43

96

49

Current assets

Inventories

320

273

273

Trade and other receivables

460

340

320

Cash and cash equivalents

197

643

348

Current tax asset

-

30

28

977

1,286

969

Total assets

1,020

1,382

1,018

Current liabilities

Trade and other payables

459

(284)

197

Non-current liabilities

Provisions for liabilities and charges

11

(13)

7

Total liabilities

470

(297)

204

Net assets

550

1,085

814

Equity

Share capital

613

613

613

Share premium account

7,361

7,361

7,361

Retained earnings

(7,424)

(6,889)

(7,160)

Equity shareholders' funds

550

1,085

814

This interim financial information was approved by the Board of Directors on 17 May 2011.

 

Brian S Emslie

Chairman

CONSOLIDATED CASH FLOW STATEMENT

for the six months ended 31 March 2011

Six months to

Six months to

Year to

31 March 2011

31 March 2010

30 September 2010

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Cash flows from operating activities

Operating loss

(266)

(109)

(412)

Adjustments for:

Depreciation

21

36

71

Loss on sale of property, plant and equipment

-

-

2

Increase in inventories

(47)

(40)

(40)

Increase in trade and other receivables

(140)

(124)

(103)

(Decrease)/increase in trade and other payables

266

(25)

(119)

Share-based payment charge

2

2

5

(164)

(260)

(596)

Corporation tax recovered

28

-

31

Net cash outflow from operating activities

(136)

(260)

(565)

Cash flows from investing activities

Interest received

-

1

2

Purchase of property, plant and equipment

(17)

(59)

(50)

Proceeds on disposal of property, plant and equipment

2

-

-

Net cash (used in)/generated from investing activities

(15)

(58)

(48)

Cash flows from financing activities

Issue of ordinary share capital

-

111

111

Net cash from generated from financing activities

-

111

111

Net (decrease) in cash and cash equivalents

(151)

(207)

(502)

Cash and cash equivalents at beginning of period

348

850

850

Cash and cash equivalents at end of period

197

643

348

 

NOTES TO THE UNAUDITED INTERIM FINANCIAL STATEMENTS

for the six months ended 31 March 2011

1 Basis of preparation

The interim financial information for the six months ended 31 March 2011 has been prepared under International Financial Reporting Standards ('IFRS') as adopted by the EU in accordance with International Accounting Standard 34 'Interim Financial Reporting'. The interim financial statements have been prepared in accordance with the Company's accounting policies under IFRS and the historical cost convention. The interim financial statements are neither audited nor reviewed, and do not constitute statutory accounts as defined by Section 434 of the Companies Act 2006. The comparatives for the financial year ended 30 September 2010 are not the Company's full statutory accounts for the year. The auditors' report on those accounts was unqualified and did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies.

2 Going concern

The interim financial information has been prepared on a going concern basis, which assumes that the Company will have adequate resources to continue in operational existence for the foreseeable future.

3 Earnings per share ('EPS')

Basic loss per ordinary share is based on the loss on ordinary activities after taxation of £266,000 and on 61,267,932 ordinary shares in issue throughout the period.

 

IAS 33 requires presentation of diluted EPS when a company could be called upon to issue shares that would decrease net profit or increase net loss per share. For a loss-making company with outstanding share options, net loss per share would only be increased by the exercise of out-of-the-money options. Since it seems inappropriate to assume that option holders would act irrationally, and there are no other diluting future share issues, diluted EPS equals basic EPS.

4 IFRS 2 'Share-based Payments'

Operating expenses includes a charge of £2,000 (2010: £2,000) after valuation of the Company's employee share option schemes in accordance with IFRS 2 'Share-based Payments'. Under this standard, the fair value of the options at the grant date is spread over the vesting period. These items have been added back in the consolidated statement of changes in equity.

5 Additional copies

Further copies of the interim report 2011 are available on the Company's website, www.ish.co.uk, and from the Company's registered office, 16-18 Hayhill Industrial Estate, Sileby Road, Barrow-upon-Soar, Leicestershire LE12 8LD.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFVREEIDLIL
Date   Source Headline
30th Apr 20247:00 amRNSInterim Results
29th Apr 20247:00 amRNSInitial c£300k order for new Portable X-Ray System
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding
18th Jan 20238:52 amRNSPosting of annual report and notice of AGM
17th Jan 20233:23 pmRNSImage Scan makes first sale of new product
23rd Dec 202211:54 amRNSDirector/PDMR Shareholding
14th Dec 20224:14 pmRNSAppointment of Director
13th Dec 20224:25 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSFinal Results
9th Dec 20227:00 amRNSNotice of Results
6th Oct 20227:00 amRNSTrading Update
1st Aug 20224:10 pmRNSHolding(s) in Company
25th May 20227:00 amRNSBoard Changes
27th Apr 20227:00 amRNSInterim Results
3rd Mar 20227:00 amRNSNew Industrial Customer
22nd Feb 20223:03 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Statement
20th Jan 202211:53 amRNSPosting of Accounts & AGM Notice
12th Jan 20227:00 amRNSLaunch of new portable X-ray system
10th Dec 20219:05 amRNSInvestor Presentation
7th Dec 202110:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
7th Dec 20217:00 amRNSFinal Results
10th Nov 20211:16 pmRNSAppointed global distributor for Serstech AB
10th Nov 20217:00 amRNSPortable x-ray sale to US Federal Agency
3rd Nov 20217:00 amRNSPre-Close Trading Update
27th Oct 20219:32 amRNSDirector Declaration
13th Sep 20217:00 amRNSTrading Update – New Orders
17th Jun 20217:00 amRNSFirst portable X-Ray sale to Australia
28th Apr 202110:03 amRNSInterim Report - Replacement
28th Apr 20217:00 amRNSNew order
28th Apr 20217:00 amRNSInterim Report
23rd Feb 202111:18 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.